Program Leaders The Center organizes its cancer research into nine established scientific research programs that span the basic, clinical, translational, and population sciences: Cancer Cell Biology. Immunology, Molecular Therapeutics. Virology. Cancer Genetics, Clinical Research, Breast Cancer, Cancer Prevention and Control, and Cancer Epidemiology. Each program is led by outstanding researchers. With one exception, each program has 0.10 FTE devoted to its leadership. The exception is Clinical Research, the Center's largest program, which has 0.15 FTE. Five programs have single leaders;four have Program Co-Leaders. Program Leader responsibilities include: advising the Director on the Center's continued scientific and intellectual development and strategic planning;developing and promoting individual and collaborative research projects, advising and mentoring program members;organizing retreats, meetings. interest groups, and seminars;promoting interactions and collaboration both inside and outside the program;and advising the Director on Center operation. To meet these responsibilities. Program Leaders interact both formally (program meetings. retreats, etc) and informally with each other, program members, and other Center members. Program Leaders also interact both formally and informally with Senior Leaders. Formal interactions include the Program Planning Committee, retreats, core facility reviews, and individual/small group meetings with the Director. Informal interactions include individual meetings, faculty meetings, seminars, symposia, and committee meetings. Program Leaders meet with the Scientific Advisory Board and ad hoc consultants.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-37
Application #
8392151
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-12-01
Budget End
2013-11-30
Support Year
37
Fiscal Year
2013
Total Cost
$255,532
Indirect Cost
$72,665
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Cholon, Deborah M; Gentzsch, Martina (2018) Recent progress in translational cystic fibrosis research using precision medicine strategies. J Cyst Fibros 17:S52-S60
Tappata, Manaswita; Eluri, Swathi; Perjar, Irina et al. (2018) Association of mast cells with clinical, endoscopic, and histologic findings in adults with eosinophilic esophagitis. Allergy 73:2088-2092
Che, Tao; Majumdar, Susruta; Zaidi, Saheem A et al. (2018) Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor. Cell 172:55-67.e15
Hu, Peirong; Bi, Yanmin; Ma, Hong et al. (2018) Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization. Gene Ther 25:454-472
Townsley, Loni; Yannarell, Sarah M; Huynh, Tuanh Ngoc et al. (2018) Cyclic di-AMP Acts as an Extracellular Signal That Impacts Bacillus subtilis Biofilm Formation and Plant Attachment. MBio 9:
Schulfer, Anjelique F; Battaglia, Thomas; Alvarez, Yelina et al. (2018) Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice. Nat Microbiol 3:234-242
Hall, Marissa G; Mendel, Jennifer R; Noar, Seth M et al. (2018) Why smokers avoid cigarette pack risk messages: Two randomized clinical trials in the United States. Soc Sci Med 213:165-172
van Haren, Jeffrey; Charafeddine, Rabab A; Ettinger, Andreas et al. (2018) Local control of intracellular microtubule dynamics by EB1 photodissociation. Nat Cell Biol 20:252-261
Gopal, Satish; Gross, Thomas G (2018) How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa. Blood 132:254-263
Deng, Jiehui; Wang, Eric S; Jenkins, Russell W et al. (2018) CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation. Cancer Discov 8:216-233

Showing the most recent 10 out of 1525 publications